Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record with an error screen. The added 403 snippet appears at the top and the surrounding study content appears removed, indicating an access issue affecting viewing of the trial information.SummaryDifference19%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision tag was updated to v3.6.6, indicating an administrative update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded a link to the PHOENIX trial website that contains information about the trial and its participating centers. The sponsor attribution and related labeling were updated to list Biogen as sponsor and include a 'Helpful Links Provided by' note.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small administrative update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/versioning rather than a change to the study data itself.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, signaling a small update to the study record metadata.SummaryDifference0.0%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.